DRDO developed poly-herbal medicine to treat Leucoderma

Defence Research and Development Organisation (DRDO) has developed a poly-herbal medicine by the trade name of Lukoskin for the treatment of Leucoderma.
It was announced by Union Defence Minister Manohar Parrikar in a written reply to Rajya Sabha. The medicine was developed by Haldwani (Uttarakhand) based scientists of Defence Bio-Energy Research (DIBER), which is a laboratory of DRDO under the aegis of the Union Defence Ministry.
Lukoskin is an ointment which has seven ingredients of plants having properties such as anti-blister, skin photo sensitizer, anti-irritation, wound healing, anti-septic and copper supplementing properties.
DRDO has transferred technology of the herbal product to private firm AIMIL Pharmaceutical Private Limited for commercial production and marketing. This private firm will introduce it in market.

About Leucoderma

Leukoderma (also known as vitiligo) is a cutaneous acquired condition causing a rare skin disease which results white patches on skin. This condition is caused due to loss of pigmentation of the skin that may occur after any number of inflammatory skin conditions such as burns, postdermabrasion, intralesional steroid injections etc. It is neither a infectious nor contagious disease but largely a cosmetic problem.


Month: 

4 Comments

  1. gowtham

    August 28, 2015 at 9:43 am

    indian scientist will rule the world in future

    Reply
  2. gowtham

    August 28, 2015 at 9:43 am

    indian scientist will rule the world in future

    Reply
  3. kamal

    March 21, 2016 at 5:59 pm

    DRDO developed a poly herbal medicine for the treatment of leucoderma. This information is New Hope for vitiligo patients. because mostly people haven’t enough money for surgery.

    Reply
  4. kamal

    March 21, 2016 at 5:59 pm

    DRDO developed a poly herbal medicine for the treatment of leucoderma. This information is New Hope for vitiligo patients. because mostly people haven’t enough money for surgery.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *